Amy S. Butler
Corporate Officer/Principal bei The International Union of Basic & Clinical Pharmacology
Ursprung des Netzwerks ersten Grades von Amy S. Butler
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
The International Union of Basic & Clinical Pharmacology
1
| Private Company | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Amy S. Butler
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Celentyx Ltd.
 Celentyx Ltd. BiotechnologyHealth Technology Celentyx Ltd. provides research and development on human immune disease. The firm's services include rapid analysis screening of drug action on physiological and pathological human immune tissues and cells. It provides services by disease, cell type, assay through its ImmuKnowlogy platform technology. The company was founded by Nicholas Mark Barnes and John Gordon in 2004 and is headquartered in Birmingham, the United Kingdom. | Biotechnology | Founder | |
| University of Birmingham | College/University | Corporate Officer/Principal |
Statistik
International
| Vereinigtes Königreich | 3 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Nicholas Mark Barnes | 3 |
- Börse
- Insiders
- Amy S. Butler
- Unternehmensverbindungen
